Latest news with #StadaArzneimittelAG
Bloomberg
28-04-2025
- Business
- Bloomberg
German Drugmaker Stada Set to Refinance Debt After IPO Delay
Takeaways NEW German drugmaker Stada Arzneimittel AG is looking to refinance some of its junk debt, after pushing back a planned initial public offering intended to cut its liabilities. Stada launched the sale of notes worth €965 million on Monday, with the proceeds earmarked for refinancing the company's 7.5% senior secured bonds due 2026. The firm may also look to refinance some of its loans shortly, according to people familiar with the matter who asked not be identified because the talks are private.
Bloomberg
17-03-2025
- Business
- Bloomberg
German Drugmaker Stada Is Pushing Back IPO Until September
Stada Arzneimittel AG 's private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said. Bain Capital and Cinven decided to delay the listing due to the recent market volatility, the people said, asking not to be identified because the information is private. They had originally planned to launch the share sale as soon as this week, according to the people.
